Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Wiley Interdisciplinary Reviews. Systems Biology and Medicine
|
July 19, 2011
Mechanistic modeling to investigate signaling by oncogenic Ras mutants
Edward C Stites, Kodi S Ravichandran
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2009
A systems perspective of ras signaling in cancer
Edward C Stites, Kodi S Ravichandran
Med (New York, N.Y.)
|
September 1, 2020
The Interpretation of SARS-CoV-2 Diagnostic Tests
Edward C Stites, Craig B Wilen
Molecular & Cellular Oncology
|
May 9, 2022
How often is each gene mutated within the cancer patient population?
Gaurav Mendiratta, Michael K Jones, Edward C Stites
Cell Communication and Signaling : CCS
|
November 6, 2020
Discernment between candidate mechanisms for KRAS G13D colorectal cancer sensitivity to EGFR inhibitors
Thomas McFall, Noah K Schomburg, Kent L Rossman, et al.
Science (New York, N.Y.)
|
October 20, 2007
Network analysis of oncogenic Ras activation in cancer
Edward C Stites, Paul C Trampont, Zhong Ma, et al.
Nature Communications
|
October 14, 2021
Cancer gene mutation frequencies for the U.S. population
Gaurav Mendiratta, Eugene Ke, Meraj Aziz, et al.
Med (New York, N.Y.)
|
June 22, 2024
Cancer research is not correlated with driver gene mutation burdens
Gaurav Mendiratta, David Liarakos, Melinda Tong, et al.
Cell Reports
|
January 21, 2015
Cooperation between Noncanonical Ras Network Mutations
Edward C Stites, Paul C Trampont, Lisa B Haney, et al.
The Pharmacogenomics Journal
|
March 5, 2025
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population
Adith S Arun, David Liarakos, Gaurav Mendiratta, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Wiley Interdisciplinary Reviews. Systems Biology and Medicine
|
July 19, 2011
Mechanistic modeling to investigate signaling by oncogenic Ras mutants
Edward C Stites, Kodi S Ravichandran
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2009
A systems perspective of ras signaling in cancer
Edward C Stites, Kodi S Ravichandran
Med (New York, N.Y.)
|
September 1, 2020
The Interpretation of SARS-CoV-2 Diagnostic Tests
Edward C Stites, Craig B Wilen
Molecular & Cellular Oncology
|
May 9, 2022
How often is each gene mutated within the cancer patient population?
Gaurav Mendiratta, Michael K Jones, Edward C Stites
Cell Communication and Signaling : CCS
|
November 6, 2020
Discernment between candidate mechanisms for KRAS G13D colorectal cancer sensitivity to EGFR inhibitors
Thomas McFall, Noah K Schomburg, Kent L Rossman, et al.
Science (New York, N.Y.)
|
October 20, 2007
Network analysis of oncogenic Ras activation in cancer
Edward C Stites, Paul C Trampont, Zhong Ma, et al.
Nature Communications
|
October 14, 2021
Cancer gene mutation frequencies for the U.S. population
Gaurav Mendiratta, Eugene Ke, Meraj Aziz, et al.
Med (New York, N.Y.)
|
June 22, 2024
Cancer research is not correlated with driver gene mutation burdens
Gaurav Mendiratta, David Liarakos, Melinda Tong, et al.
Cell Reports
|
January 21, 2015
Cooperation between Noncanonical Ras Network Mutations
Edward C Stites, Paul C Trampont, Lisa B Haney, et al.
The Pharmacogenomics Journal
|
March 5, 2025
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population
Adith S Arun, David Liarakos, Gaurav Mendiratta, et al.
Page
of 4